Glargine and liraglutide are effective glucose-lowering medications in type 2 diabetes
1. Compared to sitagliptin and glimepiride, glargine and liraglutide were more effective in...
Read MoreSep 28, 2022
1. Compared to sitagliptin and glimepiride, glargine and liraglutide were more effective in...
Read MoreSep 28, 2022
1. Patients in the active surveillance group who had forgone surgery had no difference in survival...
Read MoreSep 28, 2022
1. 25.8% of patients receiving chemotherapy for breast cancer experienced worsening frailty status. 2. Patients with both biomarkers (IL-6 and CRP) elevated before chemotherapy had a significantly higher risk of decline in...
Read MoreSep 28, 2022
1. Dapagliflozin was shown to reduce the risk of disease progression and cardiovascular death in...
Read MoreSep 28, 2022
1. In patients with amyotrophic lateral sclerosis (ALS) and superoxide dismutase 1 (SOD1)...
Read MoreSep 28, 2022
1. In this randomized controlled trial, in participants with problem alcohol use, individuals in...
Read MoreSep 28, 2022
1. Lower leisure time physical activity and higher occupational physical activity were associated...
Read MoreSep 28, 2022
1. Between 2003 to 2016, there was an increase in both survival and the use of inhaled nitric...
Read MoreSep 28, 2022
Click to read this study in Clinical Cancer Research.
Read MoreSep 28, 2022
1. Compared to a control group, patients with knee osteoarthritis who engaged in online yoga had...
Read MoreSep 28, 2022
1. By week 16, 28% of patients in dupilumab reported clear or almost clear skin (IGA 0-1) compared...
Read MoreSep 28, 2022
1. In this post-hoc analysis of a randomized controlled trial, empagliflozin use in patients with...
Read MoreSep 28, 2022
1. Adjuvant pembrolizumab significantly improved disease-free survival in comparison to placebo in...
Read MoreSep 28, 2022
1. In this study, one in four retired Olympians reported physician-diagnosed osteoarthritis (OA),...
Read MoreSep 28, 2022
Click here to read this study in NEJM.
Read MoreSep 22, 2022
1. Prevalence of moderate coronary disease ranged from 0-52% amongst patients with human...
Read MoreSep 22, 2022
1. This prospective case-control study demonstrated that approximately 20% of patients with...
Read MoreSep 22, 2022
1. In this systematic review and meta-analysis, surgeries for sleep apnea showed improvements in...
Read MoreSep 22, 2022
1. In patients that developed diabetes following total pancreatectomy, those using bihormonal...
Read MoreSep 22, 2022
1. Adjuvant pembrolizumab significantly improved disease-free survival in comparison to placebo in...
Read More